¶ CanCOVID
.png)
CanCOVID is a Canadian health research initiative formed in April 2020 by Innovation, Science and Economic Development Canada (ISED) and Chief Scientific Advisor Dr. Mona Nemer.
¶ Affiliations
CanCOVID is partnered with Covid Trials Canada.[1]
¶ Funding
CanCOVID is funded by the Government of Canada through Innovation, Science and Economic Development Canada.[2] Various CanCOVID research projects were funded by the McGill Interdisciplinary Initiative in Infection and Immunity (MI4).[3]
¶ Team
CanCOVID is led by Peter Jüni, Nathan Stall, Susan Law, and Karim Keshavjee.[4] Vivek Goel is a former Network Science Advisor.
¶ External links
About. Covid Trials Canada. Retrieved May 20, 2020, from https://web.archive.org/web/20200520142316/https://covidtrials.ca/about ↩︎
Innovation, Science and Economic Development Canada. (2022, February 1). 2020–21 Departmental Results Report. Government of Canada. https://web.archive.org/web/20220518195246/https://ised-isde.canada.ca/site/planning-performance-reporting/en/departmental-results-reports/departmental-results-report-2020-21departmental-results-reports/departmental-results-report-2019-20/2020-21-departmental-results-report ↩︎
Results of MI4 Emergency COVID-19 Research Funding. MI4. Retrieved May 16, 2023, from https://web.archive.org/web/20230516234033/https://www.mcgill.ca/mi4/mi4-supported-research/emergency-covid-19-research-funding ↩︎
About. CanCOVID. Retrieved April 24, 2022, from http://archive.today/2021.12.31-111351/https://cancovid.ca/about/ ↩︎